Dr Bazhenova on the Need for Comprehensive Molecular Testing in Unresectable NSCLC

Lyudmila A. Bazhenova, MD, discusses key factors in the management of unresectable non–small cell lung cancer, emphasizing the importance of understanding and performing biomarker testing in this population.

Related Keywords

Lyudmilaa Bazhenova , ,Moores Cancer Center ,University Of California San Diego ,California San Diego ,D ,Unresectable Non Small Cell Lung Cancer ,Duvalumab ,Biomarkers ,Dna ,Rna ,Rings ,Molecular Testing ,Nsclc ,